Clinical Trials Browser

Phase 2 × Prostate Adenocarcinoma × Biopsy × Clear all

NCT06022822 2026-03-18

Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial

Phase 2 Recruiting

Prostate Adenocarcinoma

NCT06499870 2025-10-21

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Phase 2 Recruiting

Prostate Adenocarcinoma